rss icon

With the additional $20 million it seeks to raise, Armune BioScience Inc. hopes to drive growth as well as research new applications for the blood test it developed to diagnose prostate cancer.

Breaking News

September 2018
S M T W T F S
26 27 28 29 30 31 1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 1 2 3 4 5 6

Follow MiBiz